Unknown

Dataset Information

Long-term impact of fecal transplantation in healthy volunteers.


ABSTRACT:

Background

Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness of its application in the other gastrointestinal diseases. However, in the majority of studies the effects of FMT were evaluated on the patients with initially altered microbiota. The aim of our study was to estimate effects of FMT on the gut microbiota composition in healthy volunteers and to monitor its long-term outcomes.

Results

We have performed a combined analysis of three healthy volunteers before and after capsule FMT by evaluating their general condition, adverse clinical effects, changes of basic laboratory parameters, a

SUBMITTER: Goloshchapov OV 

PROVIDER: S-EPMC6938016 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature